Guidelines on Sudden Cardiac Death 2015 (TF07) - Task Force · - Edwards Lifesciences : Speaker...

Blom Nico Nothing to be declared (2012-2013-2014-2015)

Blomstrom-Lundqvist Carina

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Sanofi Aventis : AF (2012)

- Bayer : atrial fibrillation (2013)

- Pfizer : anticoagulation (2014)

- Sanofi Aventis : anticoagulation (2014)

- Bayer : anticoagulation (2014-2015)

- Bristol Myers Squibb : anticoagulation (2015)

- Boston Scientific : Arrhythmias (2015)

- Medtronic : catheter ablation of atrial fibrillation (2015)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Medtronic : AF (2012-2013-2014)

- Biotronik : Arrhythmia (2012-2013-2014)

- Octopus : Arrhythmia (2015)

- Medtronic : Atrial fibrillation (2015)

D - Research funding (departmental or institutional).- Medtronic : AF (2012-2013-2014)

- Biotronik : Arrhythmias (2012-2013-2014)

- Octopus : Arrhythmias (2015)

- Medtronic : Atrial fibrillation (2015)

Borggrefe Martin A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- St Jude Medical : Catheters (2012)

- Bard : Catheters (2012)

- VEST : Medical devices (2012)

27/08/2015

Guidelines on Sudden Cardiac Death 2015 (TF07) - Task Force

Expert Type of Relationship with Industry

For ESC Guidelines: The report below lists declarations of interest as reported to the ESC by the experts covering the period of the Guidelines production, from Task Force creation to publication.

1/46

Borggrefe Martin - Boehringer-Ingelheim : Drugs (2012-2013-2014-2015)

- Sanofi Aventis : Drugs (2012-2013-2014-2015)

- Bayer Healthcare : Drugs (2012-2013-2014-2015)

- Medtronic : Medical devices (2012-2013-2014-2015)

- Impulse Dynamics : Medical devices (2012-2013-2014-2015)

- Boston Scientific : Stents, Catheter (2012-2013-2014-2015)

- St Jude Medical : Catheters, ICD (2013-2014-2015)

- Novartis : Drugs (2013-2014-2015)

- Zoll Medical : Medical devices (2013-2014-2015)

- Daiichi Sankyo : drugs (2014-2015)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- VEST : Medical devices (2012)

- Boehringer-Ingelheim : Drugs (2012-2013-2014-2015)

- Pfizer : Drugs (2012-2013-2014-2015)

- Sanofi Aventis : Drugs (2012-2013-2014-2015)

- Medtronic : Medical devices (2012-2013-2014-2015)

- St Jude Medical : Medical devices (2012-2013-2014-2015)

- Impulse Dynamics : Medical devices (2012-2013-2014-2015)

- Zoll Medical : Medical devices (2013-2014-2015)

C - Receipt of royalties for intellectual property.- Thieme Verlag : Author ship (2012)

- Thieme Verlag : Authorship (2013-2014-2015)

Camm John A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Forest Pharmaceuticals : Azimilide (2012)

27/08/2015




2/46

Camm John - Cameron Health : All (2012-2013)

- Merck Sharp & Dohme : DSMB - Ablation (2012-2013)

- AGA : DSMB - several (2012-2013)

- Johnson & Johnson : Apixaban (2012-2013-2014)

- Bristol Myers Squibb : DSMB (2012-2013-2014)

- ChanRx : antiarhhythmic drug (2012-2013-2014-2015)

- Wiley Blackwell : Clinical Cardiology (2012-2013-2014-2015)

- Boehringer-Ingelheim : Dabigatran (2012-2013-2014-2015)

- Biotronik : DSMB - Ablation (2012-2013-2014-2015)

- Novartis : DSMB - several (2012-2013-2014-2015)

- Infobionics : ECG monitoring (2012-2013-2014-2015)

- Oxford University Press : Europace and ESC textbook (2012-2013-2014-2015)

- GlaxoSmithKline : General Advice (2012-2013-2014-2015)

- Servier : Multiple products (2012-2013-2014-2015)

- Sanofi Aventis : Multiple products (2012-2013-2014-2015)

- Menarini : Ranolazine (2012-2013-2014-2015)

- Gilead : Ranolazine (2012-2013-2014-2015)

- Bayer : Rivaroxaban (2012-2013-2014-2015)

- Medtronic : Subcutaneous monitoring (2012-2013-2014-2015)

- Bristol Myers Squibb : Apixaban (2015)

- BioControl Medical : DSMB (2015)

- Daiichi Sankyo : Edoxaban (2015)

27/08/2015




3/46

Camm John - Johnson & Johnson : Rivaroxaban (2015)

D - Research funding (departmental or institutional).- Sanofi Aventis : Edoxaban (2012)

- Servier : Antiarrhythmic drug (2012-2013-2014-2015)

- BMS/Pfizer : Apixaban (2012-2013-2014-2015)

- Daiichi Sankyo : Edoxaban (2012-2013-2014-2015)

- Richmond Pharmacology : Many phase 1 NCEs (2012-2013-2014-2015)

Elliott Perry Mark A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Shire HGT : Enzyme replacement therapy Fabry disease (2012-2013-2014-2015)

- Genzyme : Enzyme replacement therapy Fabry disease (2012-2013-2014-2015)

- Pfizer : Treatment for TTR amyloidosis (2012-2013-2014-2015)

- MyoKardia : Mutation guided therapies in cardiomyopathy (2014-2015)

D - Research funding (departmental or institutional).- Genzyme : Cardiac magenetic resonance imaging in HCM (2012-2013-2014-2015)

- Shire HGT : Clinical characterisation of Anderson-Fabry Disease (2012-2013-2014-2015)

- National Institute for Health and Clinical Excellence : Genetics of hypertrophic cardiomyopathy (2012-2013-2014-2015)

- British Heart Foundation : Hypertrophic cardiomyopathy (2012-2013-2014-2015)

Fitzsimons Donna Nothing to be declared (2012-2013-2015)

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Amgen : FH Tratment options (2014)

Hatala Robert A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Abbott : drugs (2012)

- Bayer : drugs (2012)

- Boehringer-Ingelheim : drugs (2012)

- Pfizer : drugs (2012)

27/08/2015




4/46

Hatala Robert - Servier : drugs (2012)

- Bayer : antithrombotic therapy (2013)

- Abbott : cardiovascular drugs (2013)

- Sanofi Aventis : cardiovascular drugs (2013)

- Boston Scientific : CRM (2013)

- St Jude Medical : CRM (2013)

- Biotronik : CRM (2013)

- Boehringer-Ingelheim : antithrombotic therapy (2013-2014)

- Pfizer : cardiovascular drugs (2013-2014-2015)

- Servier : cardiovascular drugs (2013-2014-2015)

- Medtronic : CRM (2013-2014-2015)

- Bayer AG : antithrombotic therapy (2014-2015)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- St Jude Medical : CRM (2012)

- Medtronic : CRM (2012-2013-2014-2015)

- Biotronik : CRM (2012-2013-2014-2015)

D - Research funding (departmental or institutional).- Medtronic : CRM (2012-2013-2014-2015)


Hindricks Gerhard A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Stereotaxis : catheter ablation (2012)

- Biosense Webster : catheter ablation (2012)

- Medtronic : Pacemaker (2012)

- St Jude Medical : Pacemaker, catheter ablation (2012)

27/08/2015




5/46

Hindricks Gerhard - Biotronik : Pacemaker, catheter ablation (2012-2013)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Stereotaxis : catheter ablation (2012)

- Biosense Webster : catheter ablation (2012)


- Biotronik : Pacemaker, catheter ablation (2012)

- St Jude Medical : Pacemaker, catheter ablation (2012-2013)

- Boston Scientific : IC, CRT, Catheter Ablation (2014-2015)

- Biotronik : ICD, CRT (2014-2015)

- St Jude Medical : ICD, CRT, Catheter Ablation (2014-2015)

C - Receipt of royalties for intellectual property.- Biosense Webster : Pacemaker, catheter ablation (2013)

D - Research funding (departmental or institutional).- St Jude Medical : catheter ablation, pacemaker (2012)

- Biotronik : catheter ablation, pacemaker (2012)

- Stereotaxis : Pacemaker, catheter ablation (2013)

- Daiichi Sankyo : atrial fibrillation, anticoagulation (2014-2015)

- Boston Scientific : ICD, CRT, Catheter Ablation (2014-2015)

- St Jude Medical : ICD, CRT, Catheter Ablation (2014-2015)

- Biotronik : ICD, CRT, Catheter Ablation (2014-2015)

- Zoll Medical : wearable ICD (2014-2015)

E - Research funding (personal).- Medtronic : Pacemaker, catheter ablation (2013)

Kirchhof Paulus A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Otsuka Pharmaceuticals Development and Commercialization (consultancy) : cardiovascular (2012-2013)

27/08/2015




6/46

Kirchhof Paulus - Boehringer-Ingelheim : cardiovascular (2012-2013-2014-2015)

- Daiichi Sankyo : cardiovascular (2012-2013-2014-2015)

- Medtronic : cardiovascular (2012-2013-2014-2015)

- Pfizer : cardiovascular (2012-2013-2014-2015)

- St Jude Medical : cardiovascular (2012-2013-2014-2015)

- Sanofi Aventis : cardiovascular (2012-2013-2014-2015)

- Meda pharma : cardiovascular (2012-2013-2014-2015)

- Bristol Myers Squibb : cardiovascular (2012-2013-2014-2015)

- Merck Sharp & Dohme : cardiovascular (2012-2013-2014-2015)

- Medscape : cardiovascular (2014-2015)

- Bayer Healthcare : cardiovascular (2015)

- Correvio : cardiovascular (2015)

- Remedica : cardiovascular (2015)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Portola Pharmaceuticals : cardiovascular (2012)

- Boehringer-Ingelheim : cardiovascular (2012-2013)

- Bayer Healthcare : cardiovascular (2012-2013)

- BMS / Pfizer alliance : cardiovascular (2012-2013)

- Gilead : cardiovascular (2013)

D - Research funding (departmental or institutional).- St Jude Medical : cardiovascular (2012-2013-2014-2015)

- Sanofi Aventis : cardiovascular (2012-2013-2014-2015)

- Meda pharma : cardiovascular (2012-2013-2014-2015)

27/08/2015




7/46

Kirchhof Paulus - Daiichi Sankyo : cardiovascular (2014-2015)

- British Heart Foundation : cardiovascular (2014-2015)


- Leducq Foundation : cardiovascular (2014-2015)

- European Union FP7 : cardiovascular (2014-2015)

- European Union horizon2020 : cardiovascular (2014-2015)

- German Centre for Heart Research (DZHK, funded by German Ministry of Education and Research) : cardiovascular (2014-2015)

Kjeldsen Keld Per Nothing to be declared (2012-2013-2014-2015)

Kuck Karl-Heinz A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Medtronic : Speaker Fees, Honorary, Consultancy (2012)

- Abbott Vascular : Speaker Fees, Honorary, Consultancy (2012)

- Cordis : Speaker Fees, Honorary, Consultancy (2012)

- St. Jude : Speaker Fees, Honorary, Consultancy (2012)

- CCM- Impulse Dynamics : Speaker Fees, Honorary, Consultancy (2012)

- Biosense Webster : Speaker Fees, Honorary, Consultancy (2012-2013-2014)

- Edwards Lifesciences : Speaker Fees, Honorary, Consultancy (2012-2013-2014-2015)

- Stereotaxis : Speaker Fees, Honorary, Consultancy (2013-2014-2015)

- Medtronic Foundation : Speaker Fees, Honorary, Consultancy (2013-2014-2015)

- St. Jude Medical : Speaker Fees, Honorary, Consultancy (2013-2014-2015)

- Biosense Webstser : Speaker Fees, Honorary, Consutlancy (2015)

Madrid Antonio Nothing to be declared (2014-2015)

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- St Jude Medical : RESYNCHRONIZATION (2012-2013)

27/08/2015




8/46

Madrid Antonio B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Medtronic : DEFIBRILLATOR (2012-2013)

Mazzanti Andrea Nothing to be declared (2012-2013-2014-2015)

Nikolaou Nikolaos B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Sanofi Aventis : Antiplatelet drugs (2012-2013)

- Amgen : Drugs for hyperlipidemia (2012-2013-2014-2015)

Norekval Tone Merete Nothing to be declared (2012-2013-2014-2015)

Priori Silvia Giuliana A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Boston Scientific : CRM (2012)


- Transgenomic : Genetics (2012)

- Medtronic : CRM (2012-2013)

- Medtronic : Cardiac Rhythm Management (2014-2015)

- Gilead Inc : antiarrhythmic drugs (2015)

- Cardiogen : Genetics (2015)

- GE Healthcare : Health products (2015)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Boston Scientific : CRM (2013)

- Boston Scientific : Cardiac Rhythm Management (2014-2015)

D - Research funding (departmental or institutional).- Gilead : antiarrhythmic drugs (2014-2015)

- Boston Scientific : epidemiology of Brugada Syndrome (2014-2015)

Spaulding Christian A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Astra Zeneca : Acute coronary syndrome (2012-2013)

- Lilly : acute coronary syndromes (2012-2013)

- Iroko Cardio : acute coronary syndromes (2012-2013)

27/08/2015




9/46

Spaulding Christian - Abiomed : cardiac support (2012-2013)

- Medtronic : coronary stents (2012-2013)

- Cordis : radial approach (2012-2013)

- Medpass : Expert for regulatory and medical issues (2013)

- Servier : Heart failure (2013)

- Abiomed : Cardiac assist (2014)

- Zoll Medical : Defibrillators (2014)

- Servier : Teaching (2014)

- The Medicines Company : Anticoagulants (2014-2015)

- Daiichi Sankyo : Antiplatelet therapy (2014-2015)

- Astra Zeneca : Antiplatelet treatment (2014-2015)

- Wallstreet Institute : Financing of start ups (2014-2015)

- Lilly : GP IIb IIIa inhibitor (2014-2015)

- GE Healthcare : Imaging (2014-2015)

- Medtronic : Interventional cardiology (2014-2015)

- Biosensors : Stents (2014-2015)

- Bayer Healthcare : Teaching (2014-2015)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Biomatrix : coronary stents (2012-2013)

- Inspire MD : Coronary stents (2013)

D - Research funding (departmental or institutional).- INSERM : cardiac arrest (2012-2013)

- CERC : Trials (2014-2015)

27/08/2015




10/46

van Veldhuisen Dirk A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- BG medicine : Diagnostics (2012)

- BioControl : Heart failure devices (2012)

- Johnson & Johnson : Heart failure drugs (2012)

- Vifor International : Intravenous Iron (2012)

- Sorbent : K extruder (2012)

- Amgen : ESA (2012-2013)

- St Jude Medical : HF devices (2013)

- BioControl : HF devices (2013)

- Novartis : HF drugs (2013)

- Johnson & Johnson : HF drugs (2013)

- Vifor International : iv iron (2013)

- Sorbent : K+extruder (2013)

- Novartis : heart failure (2014-2015)

- Cardiorentis : heart failure (2014-2015)

- Johnson & Johnson : heart failure (2014-2015)

- Vifor International : heart failure (2014-2015)

- BioControl : Heart failure (2014-2015)

D - Research funding (departmental or institutional).- St Jude Medical : arrhythmias (2014-2015)

27/08/2015




11/46

Abdrakhmanov Ayan Nothing to be declared (2013-2014-2015)

Abou El-Maaty Mervat Nothing to be declared (2013-2014-2015)

Agewall Stefan A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Böhringer Ingelheim : Anticoagulatn treatment (2013)

- Roche Diagnostics : Cardiac markers (2013)

- Orion : Heart failure (2013)

- Pfizer : Lipids (2013)

- Sanofi Aventis : Lipids (2013)

- Siemens Healthcare : Markers (2013)

- Astra Zeneca : Platelet inhibition (2013-2014-2015)

- Thermo Fischer Scientific : Cardiac markers (2014-2015)

Antoniades Loizos Nothing to be declared (2013-2014-2015)

Arenal Maiz Angel A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Biosense Webster : Ablation (2013-2014-2015)

- Boston Scientific : ICD and Ablation (2013-2014-2015)

- Medtronic : ICD and Ablation (2013-2014-2015)

D - Research funding (departmental or institutional).- Biosense Webster : Ablation (2013-2014-2015)

Baron Esquivias Gonzalo A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Bayer : Anticoagulation (2013-2014-2015)

- Boehringer-Ingelheim : Anticoagulation (2013-2014-2015)

- Daiichi Sankyo : Anticoagulation (2013-2014-2015)

- Pfizer : Anticoagulation (2013-2014-2015)

- Menarini : Ischemic disease (2015)

27/08/2015

Guidelines on Sudden Cardiac Death 2015 (TF07) - Document Reviewers



12/46

Baron Esquivias Gonzalo - Laboratorios Rovi : Ivabradine (2015)

D - Research funding (departmental or institutional).- Biotronik : Vasovagal syncope & Pacing (2013)

- Bayer : Anticoagulation (2015)

Benlamin Hisham Nothing to be declared (2013-2014-2015)

Boriani Giuseppe A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Boston Scientific : Pacemaker, cardioverter defibrillators (2013-2014-2015)

- Medtronic : Pacemaker, cardioverter defibrillators (2013-2014-2015)

- St.Jude : Pacemaker, cardioverter defibrillators (2014-2015)

- Boehringer-Ingelheim : Anticoagulants (2015)

- Biotronik : Pacemaker, cardioverter defibrillators (2015)

Budts Werner A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Occlutech : PFO and ASD closure (2014-2015)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Novartis : Hypertension (2013)

- Servier : Atherosclerosis (2013-2014-2015)

- St Jude Medical : Interventional cardiology (2013-2014-2015)

- Occlutech : Interventional cardiology (2013-2014-2015)

- Astra Zeneca : Lipids (2013-2014-2015)

- Pfizer : Lipids (2013-2014-2015)

- Actelion : Pulmonary hypertension (2013-2014-2015)

- Boston Scientific : LAA closure (2014-2015)

- Medtronic : Ceraflex - Venus valve (2015)

D - Research funding (departmental or institutional).- Actelion : Pulmonary hypertension (2013-2014)

27/08/2015




13/46

Bueno Hector A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- BMS/Pfizer : Apixaban (2013)

- Roche Pharma : Dalcetrapib (2013)

- Novartis : Relaxin (2013)

- Bayer Healthcare : Aspirin, rivaroxaban (2013-2014-2015)

- Sanofi Aventis : Clopidogrel (2013-2014-2015)

- Daiichi Sankyo : Prasugrel (2013-2014-2015)

- Eli Lilly : Prasugrel (2013-2014-2015)

- Astra Zeneca : Ticagrelor (2013-2014-2015)

- Novartis : Serelaxin (2014)

- Pfizer : Apixaban (2014-2015)

- Bristol Myers Squibb : Apixaban (2014-2015)

- Servier : ivabradine (2014-2015)

- Menarini : Ranolazine (2014-2015)

- Abbott : Absorb stent (2015)

- Novartis : Serelaxin, ACZ696 (2015)

- Ferrer Internacional : Trinomia (polypill) (2015)

D - Research funding (departmental or institutional).- Astra Zeneca : Funding of TAN-SNIP observational study. No drugs involved (2015)

E - Research funding (personal).- Astra Zeneca : Ticagrelor (2013-2014-2015)

Capodanno Davide A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Eli Lilly/Daiichi Sankyo : Antithrombotic drugs (2013-2014)

- Astra Zeneca : Antithrombotic drugs (2013-2014-2015)

27/08/2015




14/46

Capodanno Davide - Bayer : Antithrombotic drugs (2014)

- Abbott Vascular : Mitral valve repair (2014)

- Daiichi Sankyo : Antithrombotic drugs (2015)

Carerj Scipione Nothing to be declared (2013-2014-2015)

Chaib Ali Nothing to be declared (2013)

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Servier : hypertension and heart failure (2014-2015)

- Boehringer-Ingelheim : new anticoagulants (2014-2015)

Chettaoui Rafik Nothing to be declared (2013-2014-2015)

Crespo-Leiro Maria G A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Servier : ivabradine (2013)

- Novartis : relaxine (2013)

- Roche Pharma : mycophenolate mofetil (2013-2014)

- Astellas : tacrolimus (2013-2014)

- Diaxonhit : AlloMap (2014)

- Novartis : relaxine, LCZ696 (2014)

- Bioventrix : Ventricular restauration technology (2014)

- Novartis : Heart Failure (2015)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Servier : ivabradine (clinical trial) (2013-2014)

- Novartis : relaxin (clinical trial) and LCZ 696 (clinical trial) (2013-2014)

- Novartis : Heart Failure (2015)

Czerny Martin Nothing to be declared (2013-2014-2015)

Deaton M Christi Nothing to be declared (2013)

27/08/2015




15/46

Deaton M Christi A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Bayer : none (2014-2015)

- Boehringer-Ingelheim : none (2014-2015)

- Daiichi Sankyo : none (2014-2015)

- Sanofi Aventis : none (2014-2015)

Deftereos Spyridon Nothing to be declared (2013-2014-2015)

Della Bella Paolo A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- St Jude Medical : Cardiac electrophysiology (2013-2014)

- Biotronik : Cardiac electrophysiology (2013-2014)

- Biosense Webster : Cardiac electrophysiology (2013-2014)

- Boston Scientific : Electromedical (2015)

- St JuJude Medical : Electromedical (2015)

D - Research funding (departmental or institutional).- Boston Scientific : Cardiac electrophysiology (2013-2014)

- Medtronic : Cardiac electrophysiology (2013-2014)

- St Jude Medical : Cardiac electrophysiology (2013-2014)

- Biotronik : Cardiac electrophysiology (2013-2014)

- Biosense Webster : Cardiac electrophysiology (2013-2014)

- Boston Scientific : Electromedical (2015)

- St Jude Medical : Electromedical (2015)

- Biosense : Electromedical (2015)

Demir Mesut Nothing to be declared (2013-2014-2015)

Dobrev Dobromir A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Sanofi Aventis : antiarrhythmic drugs (2013)

27/08/2015




16/46

Dobrev Dobromir - Daiichi-Sankyo : novel anticoagulans (2013)

- Daiichi Sankyo : Honoraria (2014)

- Bayer Vital : Honoraria (2014)

- OMEICOS : Honoraria for consultancy services (2015)

- Daiichi Sankyo : Honoraria for educational lectures (2015)

- Servier : Honoraria for educational lectures (2015)

- Bayer Vital : Honoraria for educational lectures (2015)

Duncan Edward Nothing to be declared (2013-2014-2015)

Eckardt Lars A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Sanofi Aventis : Antiarrhythmic drugs (2013)


- Boehringer-Ingelheim : Anticoagulation (2013)

- Daiichi Sankyo : Anticoagulation (2013)

- Pfizer : Anticoagulation (2013)

- Bristol Myers Squibb : Anticoagulation (2013)

- Johnson & Johnson : Electrophysiology (2013)

- Boston Scientific : Electrophysiology (2013-2014-2015)

- Medtronic : Electrophysiology (2013-2014-2015)

- St Jude Medical : Electrophysiology (2013-2014-2015)

- Biotronik : Electrophysiology (2013-2014-2015)

- Boehringer-Ingelheim : Electrophysiology (2014-2015)

- Daiichi Sankyo : Electrophysiology (2014-2015)

- Pfizer : Electrophysiology (2014-2015)

27/08/2015




17/46

Eckardt Lars - Sanofi Aventis : Electrophysiology (2014-2015)

- Bristol Myers Squibb : Electrophysiology (2014-2015)

- Bayer AG : Electrophysiology (2014-2015)

- Johson & Johnson : Electrophysiology (2014-2015)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Biotronik : Electrophysiology (2014-2015)

- Osypka : Electrophysiology (2014-2015)

D - Research funding (departmental or institutional).- Osypka GmbH : Electrophysiology (2014-2015)

Erol Cetin A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Servier : Hypertension (2013-2014-2015)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Menarini : Hypertension (2013-2014-2015)

Etsadashvili Kakhaber A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Servier : Perindopril, Ivabradine, (2013-2014-2015)

Galderisi Maurizio Nothing to be declared (2013-2014-2015)

Geller Laszlo A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- St Jude Medical : AF ablation (2013)

- Johnson & Johnson : catheter ablation of VTs, catheter ablation of AF, resynchronization therapy (2013)

- Biotronik : pacemaker therapy, resynchronization therapy (2013)

- Medtronic : Arrhythmia (2014-2015)

- St Jude Medical : Arrhythmia (2014-2015)

- Biotronik : Arrhythmia (2014-2015)

- Johnson & Johnson : Arrhythmia (2014-2015)

- Boston Scientific : Arrhythmia (2015)

27/08/2015




18/46

Geller Laszlo B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Medtronic : Arrhythmia (2014-2015)

- St Jude Medical : Arrhythmia (2014-2015)

- Biotronik : Arrhythmia (2014-2015)

- Johnson & Johnson : Arrhythmia (2014-2015)

Gizurarson Sigfus Nothing to be declared (2013-2014)

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Pfizer : NOAC (2015)

Gorenek Bulent Nothing to be declared (2013-2014-2015)

Goronja Boris A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Astra Zeneca : arrhythmias (2013)

- GlaxoSmithKline : hypertension (2013)

- Krka Pharma : hypertension (2013)

- Bayer : speaker fee- NOAC drug (2013-2014)

- Medtronic : Cardiac Pacing, SCD, Syncope (2013-2014-2015)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Medtronic : Panorama 2 trial (2013-2014-2015)

- PLIVA : speaker fee- art. hypertension (2014-2015)

Groben Laurent A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Daiichi Sankyo : Edoxaban - Board from 11/14 (2013-2014-2015)

Haim Moti A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Boehringer-Ingelheim : NOACS (2013-2014-2015)

- Pfizer : NOACS (2013-2014-2015)

- Bayer : noacs (2015)

D - Research funding (departmental or institutional).- Boston Scientific : ICD LEADS (2013-2014)

27/08/2015




19/46

Haim Moti - Pfizer : Atrial Fibrillation (2015)

Hedman Antti A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Cardiome UK : Antiarrhythmics (2013-2014-2015)

- Boehringer-Ingelheim : Anticoagulants (2013-2014-2015)

- Bristol Myers Squibb : Anticoagulants (2013-2014-2015)

- Johnson & Johnson : Electrophysiology (2013-2014-2015)

Hlivak Peter A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Abbott : speaker fees: ECG training (2013-2014)

- Bayer : speaker fees: SPAF - thromboprophylaxis in AF (2013-2014-2015)

- Pfizer : speaker fees: SPAF - thromboprophylaxis in AF (2013-2014-2015)

- Abbott : speaker fees: antiarrhytmic therapy /role of propafenone in AF treatment/ (2015)

D - Research funding (departmental or institutional).- Medtronic : monitoring of AF, ILR (2013)

Jensen-Urstad Mats A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Medtronic : Electrophysiology (2013-2014-2015)

- Johnson & Johnson : Electrophysiology (2015)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Medtronic : Electrophysiology (2014-2015)

D - Research funding (departmental or institutional).- St Jude Medical : Electrophysiology (2013)

- Medtronic : Electrophysiology (2013-2014-2015)

Kalejs Oskars A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Astra Zeneca : Cardiovascular Pharmacotherapy (2013-2014-2015)

- Abbott : Cardiovascular Pharmacotherapy. (2013-2014-2015)

- Boehringer-Ingelheim : Cardiovascular Pharmacotherapy. (2013-2014-2015)

- Novartis : Cardiovascular Pharmacotherapy. (2013-2014-2015)

27/08/2015




20/46

Kalejs Oskars - Servier : Cardiovascular Pharmacotherapy. (2013-2014-2015)

- Bayer AG : Cardiovascular Pharmacotherapy. (2013-2014-2015)

- Pfizer : Cardiovascular Pharmacotherapy (2015)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Biosense Webster : Treatment of Atrial Fibrillation, Catheter Ablation (2013-2014-2015)

D - Research funding (departmental or institutional).- Latvian Research Institute of Cardiology : Treatment of Heart Failure (2013-2014-2015)

Kamcevska-Dobrkovic Lidija

Nothing to be declared (2013-2014-2015)

Kampus Priit A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Berlin Chemie AG : Central blood pressure and betablockers (2013-2014-2015)

D - Research funding (departmental or institutional).- Estonian Research Council : Arterial stiffness and blood pressure (2013-2014-2015)

- Berlin Chemie AG : Central blood pressure and betablockers (2013-2014-2015)

Kautzner Josef A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Abbott : drugs (2013)

- GE Healthcare : X ray, echocardiography, imaging software (2013)

- Hansen Medical : robotic technology for ablation (2013-2014)

- Siemens Healthcare : X ray, echocardiography, imaging software (2013-2014)

- Biosense Webster : catheters, mapping system (2013-2014-2015)

- Bayer : drugs (2013-2014-2015)

- Boehringer-Ingelheim : drugs (2013-2014-2015)

- Boston Scientific : pacemakers, ICDs (2013-2014-2015)

- Medtronic : pacemakers, ICDs (2013-2014-2015)

- Biotronik : pacemakers, ICDs, catheters (2013-2014-2015)

- St Jude Medical : pacemakers, ICDs, catheters, mapping system (2013-2014-2015)

27/08/2015




21/46

Kautzner Josef - Daiichi Sankyo : drugs (2014-2015)

- Resmed : ventilators, diagnostics (2015)

D - Research funding (departmental or institutional).- Endosense : catheters (2013)

- Biosense Webster : catheters, mapping system (2013-2014-2015)

- Boston Scientific : pacemakers, ICDs (2013-2014-2015)

- Biotronik : pacemakers, ICDs, catheters (2013-2014-2015)

- Daiichi Sankyo : drugs (2014-2015)

Keane David Tj A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- lake regional medical : arrhythmias - consultancy (2013-2014-2015)

- Johnson & Johnson : arrhythmias - speaker (2013-2014-2015)

C - Receipt of royalties for intellectual property.- Medtronic : Ablation - investigational (2013-2014-2015)

Kolh Philippe H A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- B.Braun : Surgical instruments (2013-2014)

- Astra Zeneca : Antiplatelet agents (2013-2014-2015)

D - Research funding (departmental or institutional).- St Jude Medical : Cardiac valves (2013)

- Boston Scientific : Coronary stents (2013)

- Siemens Healthcare : Medical imaging (2013)

- Johnson & Johnson : Thoracoscopic devices (2013)

- Edwards Lifesciences : Cardiac valves (2013-2014-2015)

- Medtronic : Cardiac valves (2013-2014-2015)

Kriebel Thomas A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- AOP Orphan Pharmaceuticals : Consultant (2013)

- AOP Orphan Pharmaceuticalsl : Product (2014-2015)

27/08/2015




22/46

Kriebel Thomas B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Medtronic : EcG course (2014)

- St Jude Medical : Ecg course (2014)

- Nestle : Ecg course (2014-2015)

- Mortara : ECG course (2014-2015)

- Nestle : symposium (2015)

Lambiase Pier A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Boston Scientific : Devices (2013-2014-2015)

D - Research funding (departmental or institutional).- Medtronic : Devices (2013-2014-2015)

- Boston Scientific : Devices/Electrophysiology (2013-2014-2015)

- St Jude Medical : Electrophysiology (2013-2014-2015)

- Acutus : Electrophysiology (2013-2014-2015)

Lancellotti Patrizio A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Servier : Heart Failure (2013)

- Abbott : MitraClip (2013)

- Menarini : nebivolol (2014)

- St Jude Medical : Heart Failure (2015)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Astrazeneca : Dyslipidemia (2013)

- Boston Scientific : CRT (2014)

- Servier : procoralan (2014)

- Daiichi Sankyo : Teaching course on imaging (2015)

D - Research funding (departmental or institutional).- Actelion : Pulmonary Hypertension (2013)

27/08/2015




23/46

Lane Deirdre A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Bristol Myers Squibb/Pfizer : Atrial fibrillation (2013)

- Bayer : Atrial fibrillation (2014)

- Boehringer-Ingelheim : Atrial fibrillation (2014)

- Bristol Myers Squibb : Atrial fibrillation (2014-2015)

- Pfizer : Atrial fibrillation (2015)

D - Research funding (departmental or institutional).- Bayer Healthcare : Atrial fibrillation (2013)

- Boehringer-Ingelheim : Atrial fibrillation (2013-2014-2015)

- Bristol Myers Squibb : Atrial fibrillation (2014-2015)

Lang Irene Marthe A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Actelion : Bosentan (2013)

- Cordis : Cypher (2013)

- Astra Zeneca : Rosiglitazone (2013)

- Lilly : Tadalafil, ReoPro (2013)

- Merck Sharp & Dohme : Vernakalant (2013)

- GlaxoSmithKline : Ambrisentan (2013-2014-2015)

- Boehringer-Ingelheim : Dabigatran (2013-2014-2015)

- Spectranetics : Laser (2013-2014-2015)

- Servier : Procoralan (2013-2014-2015)

- Medtronic : Resolute (2013-2014-2015)

- Bayer Healthcare : Riociguat (2013-2014-2015)

- Boston Scientific : stents (2013-2014-2015)

- Biotronik : stents (2013-2014-2015)

27/08/2015




24/46

Lang Irene Marthe - United Therapeutics : Treprostinil (2013-2014-2015)

- Actelion : Opsumit (2014-2015)

- Daiichi Sankyo : Prasugrel (2014-2015)

- Astra Zeneca : Rosuvastatin (2014-2015)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Servier : Clarify Registry (2013-2014-2015)

- Bayer Healthcare : CTEPH Academy Vienna (2015)

D - Research funding (departmental or institutional).- Actelion : Bosentan (2013-2014-2015)

- Bayer : research funding (2014-2015)

Larsen Jacob Moesgaard B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Pfizer : one speakers fee (<300 Euro) payed to my institution (2015)

E - Research funding (personal).- Danish Heart Foundation : Founding of PhD-study on ICD-leads (2013)

- Danish Heart Foundation : ICD leads (2014)

Lenarczyk Radoslaw A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Boehringer-Ingelheim : Producer of drugs (2013-2014-2015)

- Medtronic : Producer of pacemakers, ICDs, CRT-devices (2013-2014-2015)

- St Jude Medical : Producer of pacemakers, ICDs, CRT-devices (2013-2014-2015)

- Biotronik : Producer of pacemakers, ICDs, CRT-devices (2013-2014-2015)

Lip Gregory Y H A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Astellas : atrial fibrillation, thrombosis (2013)

- Biotronik : atrial fibrillation (2013-2014-2015)

- Boehringer-Ingelheim : atrial fibrillation, thrombosis (2013-2014-2015)

- Daiichi Sankyo : atrial fibrillation, thrombosis (2013-2014-2015)

- Pfizer : atrial fibrillation, thrombosis (2013-2014-2015)

27/08/2015




25/46

Lip Gregory Y H - Bayer Healthcare : atrial fibrillation, thrombosis (2013-2014-2015)

- Bristol Myers Squibb : atrial fibrillation, thrombosis (2013-2014-2015)

- Medtronic : atrial fibrillation (2014-2015)

- Roche Diagnostics : anticoagulation (2015)

D - Research funding (departmental or institutional).- Bayer : atrial fibrillation, thrombosis (2013)

- Daiichi Sankyo : atrial fibrillation, thrombosis (2014-2015)

Mairesse Georges H A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Bayer Healthcare : NOAC (2013-2014)

- Boehringer-Ingelheim : NOAC (2013-2014-2015)

- Daiichi Sankyo : NOAC (2013-2014-2015)

- Bristol Myers Squibb : NOAC (2013-2014-2015)

- Medtronic : pacemakers (2013-2014-2015)

- Johnson & Johnson : AF (2014-2015)

- Servier : If inhibitors (2014-2015)

- Sorin Group : pacemakers (2014-2015)

- Biotronik : pacemakers - telemonitoring (2014-2015)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Sanofi Aventis : Dronédarone (2013)

- Daiichi Sankyo : NOAC (2013)


- Bristol Myers Squibb : NOAC (2013-2014-2015)

- Sorin Group : Pacemaker (2013-2014-2015)

- St Jude Medical : Pacemaker (2013-2014-2015)

27/08/2015




26/46

Mairesse Georges H - Boehringer-Ingelheim : NOAC (2014-2015)

- Biotronik : pacemaker study (2014-2015)

D - Research funding (departmental or institutional).- St Jude Medical : Pacemaker (2013-2014-2015)

Manolis Athanasios John A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Abbott : Hypertension, (2013-2014-2015)

- Menarini : hypertension, heart failure (2013-2014-2015)

- Bayer AG : atrial fibrillation (2014-2015)

- Servier : hypertension (2014-2015)

- Berlin Chemie AG : hypertension (2014-2015)

- Ferrer Internacional : hypertension (2014-2015)

- Recordati International : hypertension (2014-2015)

D - Research funding (departmental or institutional).- Bayer : AF (2013-2014-2015)

- Boehringer-Ingelheim : AF (2013-2014-2015)

- GlaxoSmithKline : Coronary Heart Diseaese (2013-2014-2015)

- Servier : Heart Failure (2013-2014-2015)

- Amgen : hyperlipidemia (2014-2015)

- Sanofi Aventis : hyperlipidemia (2014-2015)

Marinskis Germanas Nothing to be declared (2013-2014)

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- BackBeat Medical : Pacemaker (2015)

Mikhaylov Evgeny A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Medtronic : Medical devices (2013-2014-2015)

- Biosense Webster : Medical devices (2013-2014-2015)

27/08/2015




27/46

Mikhaylov Evgeny B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Biosense Webster : Medical devices (2013-2014-2015)

Mirrakhimov Aibek Nothing to be declared (2013-2014-2015)

Morais Joao A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- JaBA Recordati : Lipids and Hypertension (2013)

- Merck Sharp & Dohme : Lpids (2013)

- Bayer Healthcare : Rivaroxaban (2013)

- Astra Zeneca : Ticagrelor (2013)

- Daiichi Sankyo : anticoagulants (2014)

- Merck Sharp & Dohme : lipids (2014)

- Boehringer-Ingelheim : anticoagulants (2014-2015)

- Pfizer : anticoagulants (2014-2015)

- Bayer Healthcare : anticoagulants (2014-2015)

- BMS : anticoagulants (2014-2015)

- Astra Zeneca : antiplatelets (2014-2015)

- Eli Lilly C : antiplatelets (2014-2015)

- Daiichi Sankyo : antiplatelets (2015)

- Merck Sharp & Dohme : lipids and antiplatelets and diabetes (2015)

E - Research funding (personal).- Servier : ivabradin (2013)

- Servier : ischemic heart disease (2014)

Moreno Planas Javier A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Medtronic : Defibrillators (2013)

- Sorin Group : Defibrillators (2013-2014-2015)

27/08/2015




28/46

Moreno Planas Javier - Boston Scientific : Defibrillators, EP catheters (2013-2014-2015)

- St Jude Medical : Defibrillators, EP catheters (2013-2014-2015)

- Biotronik : Defibrillators, EP catheters (2013-2014-2015)

- Biosense Webster : EP catheters (2013-2014-2015)

- Medtronic : Defibrillators, EP catheters (2014-2015)

Morgado Francisco Bello A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Sorin Group : CRT (2013)

- St Jude Medical : CRt (2013-2014-2015)

- Bayer : NOAC (2013-2014-2015)

- Pfizer : NOAC (2014-2015)

Parkhomenko Alexander A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Servier : trimetazidin, rivaroxaban, ticagrelor (2013-2014)

- BHFZ : corvitin (2015)

- Bayer Healthcare : rivaroxaban (2015)

- Astra Zeneca : ticagrelor (2015)

- Servier : trimetazidine (2015)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Bayer : rivaroxabane (2013-2014)

C - Receipt of royalties for intellectual property.- BHFZ : corvitine (2013-2014)

D - Research funding (departmental or institutional).- European Research Foundation FP7 : biomarkers (2015)

Piepoli Massimo Francesco Nothing to be declared (2013-2014-2015)

Piot Olivier A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- BMS : antithrombotic (2013)

- St Jude Medical : IPG, ICD (2013)

27/08/2015




29/46

Piot Olivier - Medtronic : IPG, ICD, Ablation catheter (2013)

- Bristol Myers Squibb : DOA (2014)

- Medtronic : IPG, ICD, Ablation (2014)

- St Jude Medical : IPG, ICD, Ablation (2014)

- Bayer : DOA (2015)

- BMS Pfizer : DOA (2015)

- Medtronic : IPG/ICD (2015)

- Sorin Group : IPG/ICD (2015)

- saint Jude medical : IPG/ICD (2015)

E - Research funding (personal).- St Jude Medical : CRT (2013)

Piruzyan Armen A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Bayer : NOACs-Rivaroxaban (2013-2014)

- Takeda Pharmaceuticals : Bisoprolol (2013-2014-2015)

- Servier : Ivabradine,Triplexam (2013-2014-2015)

- Krka Pharma : Statines (2013-2014-2015)

Puljevic Davor Nothing to be declared (2013-2014-2015)

Raducan Aurica Nothing to be declared (2013-2014-2015)

Roithinger Franz Xaver A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Bayer : Anticoagulation (2013-2014-2015)




27/08/2015




30/46

Roithinger Franz Xaver B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Bristol Myers Squibb : Anticoagulation (2013-2014-2015)

- Biotronik : Device Therapy (2013-2014-2015)

- Biosense Webster : Electrophysiology (2013-2014-2015)

D - Research funding (departmental or institutional).- Astra Zeneca : Platelet inhibition (2013-2014-2015)

Rutten Frans Hendrik D - Research funding (departmental or institutional).- Boehringer-Ingelheim : anticoagulants (2013)

- Boehringer-Ingelheim : Atrial fibrillation (2014-2015)

Sammut Mark Adrian Nothing to be declared (2013-2014-2015)

Shalganov Tchavdar A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Pfizer : apixaban (2013-2014)

- Actavis : ECG training of family physicians (2013-2014)

- Bayer : rivaroxaban (2014-2015)

Sredniawa Beata A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Boehringer-Ingelheim : Pradaxa (2013-2014-2015)

- Adamed : Nebilenin (2014)

- Bayer : Xarelto (2015)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Adamed : Nebilenin (2013-2014)

D - Research funding (departmental or institutional).- Zoll Medical : Therapeutic Hypothermia (2013-2014-2015)

E - Research funding (personal).- Zoll Medical : Therapeutic Hypothermia (2013-2014-2015)

Sticherling Christian A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Bard : Ablation therapy (2013-2014)

- Bristol Myers Squibb : Anticoagulants, atrial fibrillation (2013-2014)

27/08/2015




31/46

Sticherling Christian - Bayer : Anticoagulants, atrial fibrillation (2013-2014-2015)

- Medtronic : Defibrillators, Pacemaker (2013-2014-2015)

- Sorin Group : Defibrillators, Pacemaker (2013-2014-2015)

- Biotronik : Defibrillators, Pacemaker, (2013-2014-2015)

- Boehringer-Ingelheim : anticoagulants, atrial fibrillation (2015)

- Daiichi Sankyo : anticoagulants, atrial fibrillation (2015)

- Boston Scientific : Defibrillator, Pacemaker (2015)

D - Research funding (departmental or institutional).- Biosense Webster : Atrial fibrillation (2013-2014-2015)

- Biotronik : CRT (2013-2014-2015)

Tande Pal Morten Nothing to be declared (2014-2015)

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- St Jude Medical : Ablation technology (2013)

Vatasescu Radu-Gabriel Nothing to be declared (2013-2014-2015)

Zamorano Gomez Jose Luis

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Daiichii : Atrial Fib (2013)

- Merck Sharp & Dohme : Lipid Lowering (2013)

- Philips : 3D echo (2014)

- Toshiba medical imaging : fusion imaging 3D echo CT (2014)

- Astra Zeneca : Speaker fee for 1 talk in 2014 (2014)

- MSD : CV risk factors (2014-2015)

- Abbott : Lecturing (2015)

- Astra Zeneca : Lecturing (2015)

- Pfizer : Lecturing (2015)

27/08/2015




32/46


- Sorin Group : Respicardia echo protocol (2015)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- European Research FP7 : CV Imaging (2013)

- Servier : Imaging in ISchemic patients (2013)

- Siemens Healthcare : 3d echo software and free style echo (2014-2015)

- Toshiba medical imaging : Fusion Imaging (2015)

C - Receipt of royalties for intellectual property.- Springer : ESC Textbook of CV Imaging (2013)

D - Research funding (departmental or institutional).- Amgen : Clinical trial (2014-2015)

- Novartis : Clinical trial (2014-2015)

- Ikaria : Clinical trial (2014-2015)

Zannad Faiez A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Biotronik : heart failure (2013)

- Novartis : aliskiren (2013-2014)

- Takeda Pharmaceuticals : diabetes (2013-2014-2015)

- Pfizer : eplerenone (2013-2014-2015)

- Boston Scientific : heart failure (2013-2014-2015)

- Servier : heart failure (2013-2014-2015)

- Bayer Healthcare : heart failure (2013-2014-2015)

- Janssen-Cilag : Rivaroxaban (2013-2014-2015)

- Resmed : sleep apena (2013-2014-2015)

- Astra Zeneca : cardiovascular (2014-2015)

- Merck Sharp & Dohme : diabetes (2014-2015)

27/08/2015




33/46

Zannad Faiez - Mitsubishi : heart failure (2014-2015)

- Air liquide : oxygen (2014-2015)

- Eli Lilly : heart failure (2015)

- Novartis : heart failure (2015)

- Quantum Genomics : Heart Failure (2015)

- Stealth Peptide : Heart failure (2015)

- Relypsa : patiromer (2015)

- ZS Pharma : ZS9 (2015)

D - Research funding (departmental or institutional).- Roche Diagnostics : biomarker (2013-2014-2015)

E - Research funding (personal).- Roche Diagnostics : biomarker (2013)

Zeppenfeld Katja A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- St Jude Medical : 3D mapping systems (2013)

D - Research funding (departmental or institutional).- Boston Scientific : ICD, pacemaker (2013-2014-2015)

- Medtronic : ICD, pacemaker (2013-2014-2015)

- Biotronic : ICD, pacemaker (2013-2014-2015)

- Edwards Lifesciences : percutaneous valve (2013-2014-2015)

27/08/2015




34/46

Aboyans Victor Nothing to be declared (2013)

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Astra Zeneca : Antithrombotics (2014)

- Sanofi Aventis : Hyperlipidemia (2014)

- Boehringer-Ingelheim : Oral anticoagulation (2014)

- Pfizer/BMS alliance : Oral anticoagulation (2014)

- Novartis : Hypertension (2014-2015)

- Bayer Healthcare : Oral anticoagulation (2014-2015)

- Merck Sharp & Dohme : Antithrombotics (2015)

Achenbach Stephan A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Bayer : Anticoagulation (2013)

- Behring : Anticoagulation (2013)

- Astra Zeneca : Antiplatelet Therapy (2013)

- Abbott : Coronary Intervention (2013)

- Siemens Healthcare : CT (2013)

- Servier : Imaging (2013)

- Guerbet : Imaging (2013)

D - Research funding (departmental or institutional).- Abbott : Coronary Intervention (2013-2014)

- Siemens Healthcare : Imaging (2013-2015)

Agewall Stefan A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Böhringer Ingelheim : Anticoagulatn treatment (2013)

- Roche Diagnostics : Cardiac markers (2013)

- Orion : Heart failure (2013)

27/08/2015

Committee for Practice Guidelines 2014-2016 - MEMBERS



35/46

Agewall Stefan - Pfizer : Lipids (2013)

- Sanofi Aventis : Lipids (2013)

- Siemens Healthcare : Markers (2013)


- Thermo Fischer Scientific : Cardiac markers (2014-2015)

Badimon Lina A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Astra Zeneca : cardiovascular (2013)

- Sanofi Aventis : cardiovascular (2013)

- MSD-España : Lipids (2014)

- Sanofi Aventis : lipids (2014-2015)

- Burson Masteller : nutrition (2014-2015)

- Astra Zeneca : thrombosis (2014-2015)

D - Research funding (departmental or institutional).- Astrazeneca : thrombosis (2014-2015)

Baron Esquivias Gonzalo A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Bayer : Anticoagulation (2013-2014-2015)



- Pfizer : Anticoagulation (2013-2014-2015)

- Menarini : Ischemic disease (2015)

- Laboratorios Rovi : Ivabradine (2015)

D - Research funding (departmental or institutional).- Biotronik : Vasovagal syncope & Pacing (2013)


27/08/2015




36/46

Baumgartner Helmut A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Actelion : Bosentan and Macicentan for PAH treatment in congenital heart disease (2013-2014-2015)

- St. Jude Medical : Occluders for shunt closure (ASD, PFO, PDA, VSD) (2013-2014-2015)

- Abbott : transcather mitral valve repair (Mitraclip) (2013-2014-2015)

- Edwards Lifesciences : transcatheter valve implantation (2013-2014-2015)

- Direct Flow Medical : transcatheter valve implantation (2013-2014-2015)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Actelion : Bosentan for PAH treatment in congenital heart disease (2013-2014-2015)

- St. Jude Medical : Occluders for shunt closure (ASD, PFO, PDA, VSD) (2013-2014-2015)

- Abbott : transcather mitral valve repair (Mitraclip) (2013-2014-2015)

- Edwards Lifesciences : transcatheter valve implantation (2013-2014-2015)

- Direct Flow Medical : transcatheter valve implantation (2013-2014-2015)

Bax Jeroen Nothing to be declared (2014-2015)

D - Research funding (departmental or institutional).- Servier : Farma (2013)

- Edwards Lifesciences : Heart Valves (2013)

- GE Healthcare : Imaging (2013)

- Lantheus Inc : Imaging (2013)

- Boston Scientific : Pacing (2013)

- Medtronic : Pacing (2013)

- St Jude Medical : Pacing (2013)

- Biotronik : Pacing (2013)

Bueno Hector A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- BMS/Pfizer : Apixaban (2013)

27/08/2015




37/46

Bueno Hector - Roche Pharma : Dalcetrapib (2013)

- Novartis : Relaxin (2013)

- Bayer Healthcare : Aspirin, rivaroxaban (2013-2014-2015)

- Sanofi Aventis : Clopidogrel (2013-2014-2015)

- Daiichi Sankyo : Prasugrel (2013-2014-2015)

- Eli Lilly : Prasugrel (2013-2014-2015)

- Astra Zeneca : Ticagrelor (2013-2014-2015)

- Novartis : Serelaxin (2014)

- Pfizer : Apixaban (2014-2015)

- Bristol Myers Squibb : Apixaban (2014-2015)

- Servier : ivabradine (2014-2015)

- Menarini : Ranolazine (2014-2015)

- Abbott : Absorb stent (2015)

- Novartis : Serelaxin, ACZ696 (2015)

- Ferrer Internacional : Trinomia (polypill) (2015)

D - Research funding (departmental or institutional).- Astra Zeneca : Funding of TAN-SNIP observational study. No drugs involved (2015)

E - Research funding (personal).- Astra Zeneca : Ticagrelor (2013-2014-2015)

Carerj Scipione Nothing to be declared (2013-2014-2015)

Erol Cetin A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Servier : Hypertension (2013-2014-2015)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Menarini : Hypertension (2013-2014-2015)

27/08/2015




38/46

Fitzsimons Donna Nothing to be declared (2013-2015)

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Amgen : FH Tratment options (2014)

Gaemperli Oliver Nothing to be declared (2013)

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Biosensors : Stents (2014)

- Biosensors : Axxess Bifurcation Stent (2015)

- Abbott Vascular : MitraClip (2015)

- Biosensors : Travel Grant to AsiaPCR 2015 (2015)

Kirchhof Paulus A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Otsuka Pharmaceuticals Development and Commercialization (consultancy) : cardiovascular (2013)

- Boehringer-Ingelheim : cardiovascular (2013-2014-2015)

- Daiichi Sankyo : cardiovascular (2013-2014-2015)

- Medtronic : cardiovascular (2013-2014-2015)

- Pfizer : cardiovascular (2013-2014-2015)

- St Jude Medical : cardiovascular (2013-2014-2015)

- Sanofi Aventis : cardiovascular (2013-2014-2015)

- Meda pharma : cardiovascular (2013-2014-2015)

- Bristol Myers Squibb : cardiovascular (2013-2014-2015)

- Merck Sharp & Dohme : cardiovascular (2013-2014-2015)

- Medscape : cardiovascular (2014-2015)


- Correvio : cardiovascular (2015)

- Remedica : cardiovascular (2015)

27/08/2015




39/46

Kirchhof Paulus B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Boehringer-Ingelheim : cardiovascular (2013)


- Gilead : cardiovascular (2013)

- BMS / Pfizer alliance : cardiovascular (2013)

D - Research funding (departmental or institutional).- St Jude Medical : cardiovascular (2013-2014-2015)

- Sanofi Aventis : cardiovascular (2013-2014-2015)

- Meda pharma : cardiovascular (2013-2014-2015)

- Daiichi Sankyo : cardiovascular (2014-2015)

- British Heart Foundation : cardiovascular (2014-2015)


- Leducq Foundation : cardiovascular (2014-2015)

- European Union FP7 : cardiovascular (2014-2015)

- European Union horizon2020 : cardiovascular (2014-2015)

- German Centre for Heart Research (DZHK, funded by German Ministry of Education and Research) : cardiovascular (2014-2015)

Kolh Philippe H A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- B.Braun : Surgical instruments (2013-2014)

- Astra Zeneca : Antiplatelet agents (2013-2014-2015)

D - Research funding (departmental or institutional).- St Jude Medical : Cardiac valves (2013)

- Boston Scientific : Coronary stents (2013)

- Siemens Healthcare : Medical imaging (2013)

- Johnson & Johnson : Thoracoscopic devices (2013)

27/08/2015




40/46

Kolh Philippe H - Edwards Lifesciences : Cardiac valves (2013-2014-2015)

- Medtronic : Cardiac valves (2013-2014-2015)

Lancellotti Patrizio A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Servier : Heart Failure (2013)

- Abbott : MitraClip (2013)

- Menarini : nebivolol (2014)

- St Jude Medical : Heart Failure (2015)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Astrazeneca : Dyslipidemia (2013)

- Boston Scientific : CRT (2014)

- Servier : procoralan (2014)

- Daiichi Sankyo : Teaching course on imaging (2015)

D - Research funding (departmental or institutional).- Actelion : Pulmonary Hypertension (2013)

Lip Gregory Y H A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Astellas : atrial fibrillation, thrombosis (2013)

- Biotronik : atrial fibrillation (2013-2014-2015)

- Boehringer-Ingelheim : atrial fibrillation, thrombosis (2013-2014-2015)

- Daiichi Sankyo : atrial fibrillation, thrombosis (2013-2014-2015)

- Pfizer : atrial fibrillation, thrombosis (2013-2014-2015)

- Bayer Healthcare : atrial fibrillation, thrombosis (2013-2014-2015)

- Bristol Myers Squibb : atrial fibrillation, thrombosis (2013-2014-2015)

- Medtronic : atrial fibrillation (2014-2015)

- Roche Diagnostics : anticoagulation (2015)

27/08/2015




41/46

Lip Gregory Y H D - Research funding (departmental or institutional).- Bayer : atrial fibrillation, thrombosis (2013)

- Daiichi Sankyo : atrial fibrillation, thrombosis (2014-2015)

Nihoyannopoulos Petros Nothing to be declared (2014-2015)

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- GSK : Consultant for Imaging studies (2013)

Piepoli Massimo Francesco Nothing to be declared (2013-2014-2015)

Ponikowski Piotr A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Bayer : anticoagulant (2013)

- Bristol Myers Squibb : anticoagulant (2013)

- ROSCHE : diabetes (2013)

- Boehringer-Ingelheim : anticoagulant (2013-2014)

- Respicardia : anticoagulant (2013-2014)

- Johnson & Johnson : heart failure (2013-2014)

- Pfizer : heart failure, anticoagulant (2013-2014)

- Abbott Vascular : devices (2013-2014-2015)

- Novartis : heart failure (2013-2014-2015)

- Cardiorentis : heart failure (2013-2014-2015)

- Bayer Healthcare : heart failure (2013-2014-2015)

- Vifor Pharma ltd : heart failure (2013-2014-2015)

- CIBIEM : heart failure (2013-2014-2015)

- Servier : heart failure, coronary artery disease (2013-2014-2015)

- Amgen : heart failure, lipids (2013-2014-2015)

- MSD : lipids (2014)

27/08/2015




42/46

Ponikowski Piotr - Astra Zeneca : acute coronary syndrome (2014-2015)

- Boehringer-Ingelheim : anticoagulant, diabetes (2015)

- Respicardia : devices (2015)

- BioControl : devices (2015)

- DC Device : devices (2015)

- Celladon : heart failure (2015)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Vifor Pharma ltd : heart failure (2014)

- MSD : lipids (2014)

- Astra Zeneca : acute coronary syndrome (2014-2015)

- Respicardia : anticoagulant (2014-2015)

- Novartis : heart failure (2014-2015)

- Cardiorentis : heart failure (2014-2015)

- Bayer Healthcare : heart failure (2014-2015)

- CIBIEM : heart failure (2014-2015)

- Servier : heart failure, coronary artery disease (2014-2015)

- Amgen : heart failure, lipids (2014-2015)

- BioControl : devices (2015)

- DC Device : devices (2015)

- Celladon : heart failure (2015)

D - Research funding (departmental or institutional).- Vifor Pharma ltd : heart failure (2013)

- Singulex : biomarkers (2015)

27/08/2015




43/46

Roffi Marco A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Daiichi Sankyo : antiplatelet therapy (2013)

- Lilly : antiplatelet therapy (2013)

- Astra Zeneca : antipletelet therapy (2013)

- Johnson & Johnson : coronary catheters (2014)

D - Research funding (departmental or institutional).- Biosensors : devices (2013-2014-2015)

- Boston Scientific : devices (2013-2014-2015)

- Medtronic : devices (2013-2014-2015)

- Biotronik : devices (2013-2014-2015)

- Abbott Vascular : devices (2013-2014-2015)

Torbicki Adam A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Bristol Myers Squibb : Pulmonary arterial hypertension (2013-2014-2015)

- GlaxoSmithKline : pulmonary arterial hypertension - ambrisentan (2013-2014-2015)

- Lilly : pulmonary arterial hypertension - ambrisentan (2013-2014-2015)

- Actelion : pulmonary arterial hypertension - macitentan, selexipag (2013-2014-2015)

- Bayer Healthcare : pulmonary arterial hypertention - iloprost, riociguat, VTE - xarelto (2013-2014-2015)

- AOP Orphan Pharmaceuticals : pulmonary arterial hypertension (2015)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Bayer Healthcare : Pulmonary hypertension (2013-2014-2015)

Vaz Carneiro Antonio Nothing to be declared (2015)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- AbbVie : Oncology (2013-2014)

Windecker Stephan A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Astra Zeneca : Antiplatelet drug (2013)

- Eli Lilly : Antiplatelet drug (2013)

27/08/2015




44/46

Windecker Stephan - Abbott : Stent (2013)

- Medtronic : Stent (2013)

- Biotronik : Stent (2013)

- Astra Zeneca : Antiplatelet therapy (2014-2015)

- Eli Lilly : Antiplatelet therapy (2014-2015)

- Bayer Healthcare : Antithrombotic drug (2014-2015)

- Abbott : Stent and Heartvalvetherapy (2014-2015)

- Biosensors : Stents (2014-2015)

- Boston Scientific : Stents (2014-2015)

- Medtronic : TAVI, Stent (2015)

- Edwards Lifesciences : Transcatheter heart valves (2015)

D - Research funding (departmental or institutional).- St Jude Medical : OCT (2013-2014-2015)

- Biotronik : Stent (2013-2014-2015)

- Medtronic : Stent and Heartvalves (2014)

- Medicines Company : Antithrombotic therapy (2014-2015)

- Johnson & Johnson : Catheters (2014-2015)

- Edwards Lifesciences : Heartvalves (2014-2015)

- Abbott : Stent (2014-2015)

- Boston Scientific : Stent and Heartvalves (2014-2015)


A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- Daiichii : Atrial Fib (2013)

- Merck Sharp & Dohme : Lipid Lowering (2013)

27/08/2015




45/46


- Philips : 3D echo (2014)

- Toshiba medical imaging : fusion imaging 3D echo CT (2014)

- Astra Zeneca : Speaker fee for 1 talk in 2014 (2014)

- MSD : CV risk factors (2014-2015)

- Abbott : Lecturing (2015)

- Astra Zeneca : Lecturing (2015)

- Pfizer : Lecturing (2015)

- Sorin Group : Respicardia echo protocol (2015)

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.- European Research FP7 : CV Imaging (2013)

- Servier : Imaging in ISchemic patients (2013)

- Siemens Healthcare : 3d echo software and free style echo (2014-2015)

- Toshiba medical imaging : Fusion Imaging (2015)

C - Receipt of royalties for intellectual property.- Springer : ESC Textbook of CV Imaging (2013)

D - Research funding (departmental or institutional).- Amgen : Clinical trial (2014-2015)

- Novartis : Clinical trial (2014-2015)

- Ikaria : Clinical trial (2014-2015)

27/08/2015




46/46

Guidelines on Sudden Cardiac Death 2015 (TF07) - Task Force · - Edwards Lifesciences : Speaker...

Documents

Transcript of Guidelines on Sudden Cardiac Death 2015 (TF07) - Task Force · - Edwards Lifesciences : Speaker...